Skip to content

8-KAccepted Sep 14, 4:25 PM ET

Health Catalyst Appoints Tami Reller to Board; Board Expanded to Seven

HCATHealth Catalyst, Inc.

Accepted (ET)

4:25 PM

Sep 14, 2026

Filed

Sep 14, 2026

Documents

14

Size

205.4 KB

Summary

Health Catalyst Appoints Tami Reller to Board; Board Expanded to Seven

Updated

What Happened

  • Health Catalyst, Inc. filed an 8-K reporting that on September 11, 2026 the board (following the Nominating and Corporate Governance Committee’s recommendation) appointed Tami Reller to the board, effective October 1, 2026. Her appointment fills a newly created seat as the board expands from six to seven directors. Ms. Reller will serve as a Class III director until her successor is elected or she otherwise leaves the board.
  • The board also appointed Ms. Reller to the Audit Committee (as chair, replacing Justin Spencer, who will remain a committee member) and to the Compensation Committee, replacing Jill Hoggard Green on those committee roles. She will receive cash and equity under the company’s non-employee director compensation policy and will enter the company’s standard indemnification agreement.

Key Details

  • Appointment announced: September 11, 2026; effective: October 1, 2026.
  • Board size increased from six (6) to seven (7) directors to create the new seat.
  • Committee roles: Audit Committee chair (replacing Justin Spencer) and member of the Compensation Committee (replacing Jill Hoggard Green).
  • Background: Ms. Reller (age 62) previously held senior roles at Duly Health and Care (President 2021–2022; CEO 2022–2023; Chair 2023–2024), UnitedHealth/Optum, and Microsoft; she serves on the SPS Commerce board and Fairview Health Services. Education: B.S. (Univ. of Minnesota, Moorhead), MBA (St. Mary’s College).

Why It Matters

  • The appointment adds an experienced healthcare, technology and finance executive to the board and places her in charge of the Audit Committee, which oversees financial reporting and controls—an important governance change for investors evaluating oversight and risk management.
  • The board expansion and committee reshuffle are governance updates that may influence board dynamics and oversight going forward. The filing notes standard director compensation and indemnification and discloses no related-party transactions or family ties.

AI-written summary · check the filing